Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study
Jorge E. Cortes,
Jeff H. Lipton,
Vamsi Kota,
Fausto Castagnetti,
Sarit Assouline,
Tim H. Brümmendorf,
Eric Leip,
Andrea Viqueira,
Carlo Gambacorti-Passerini
Affiliations
Jorge E. Cortes
Georgia Cancer Center, Augusta, GA
Jeff H. Lipton
Princess Margaret Cancer Centre, Toronto, ON
Vamsi Kota
Georgia Cancer Center, Augusta, GA
Fausto Castagnetti
Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna
Sarit Assouline
McGill University, Montreal, QC
Tim H. Brümmendorf
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University Hospital, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD)